U-play Achieved Operating Revenue of Approximately RMB 1.168 Billion in 2025 Wuhu U-play Nursing Products Technology Co., Ltd. achieved operating revenue of approximately RMB 1.168 billion in 2025, representing a year-on-year increase of 14.43%. Net profit attributable to shareholders of the listed company was approximately RMB 36.1401 million, down 38.89% year-on-year.

Jingxing Paper Achieved Operating Revenue of Approximately RMB 6.012 Billion in 2025 Zhejiang Jingxing Paper Co., Ltd. achieved operating revenue of RMB 6.012 billion in 2025, representing a year-on-year increase of 9.72%. The tissue paper division produced 147,800 tpy of parent tissue roll, up 7.33% year-on-year, of which 137,000 tpy were directly sold externally, up 7.2% year-on-year.

OK Technology Publishes 2025 Annual Report and 2026 Q1 Report Recently, OK Technology Co., Ltd. achieved operating revenue of approximately RMB 956 million in 2025, representing a year-on-year increase of 120.01%. Net profit attributable to shareholders of the listed company was approximately RMB 40.8560 million, up 19.16% year-on-year. In the first quarter of 2026, the company achieved operating revenue of approximately RMB 256 million, up 28.33% year-on-year. Net profit attributable to shareholders of the listed company was approximately RMB 30.7723 million, down 24.08% year-on-year.

Focus Hotmelt Achieved Operating Revenue of Approximately RMB 588 Million in Q1 2026 Focus Hotmelt New Materials Co., Ltd. achieved operating revenue of approximately RMB 588 million in the first quarter of 2026, representing a year-on-year increase of 16.92%. Net profit attributable to shareholders of the listed company was approximately RMB 39.7472 million, up 11.91% year-on-year.

Xiamen Yanjan Achieved Operating Revenue of Approximately RMB 476 Million in Q1 2026 Xiamen Yanjan New Materials Co., Ltd. achieved operating revenue of approximately RMB 476 million in the first quarter of 2026, representing a year-on-year increase of 9.07%. Net profit attributable to shareholders of the listed company was approximately RMB 31.4168 million, up 182.90% year-on-year.

Jieya Achieved Operating Revenue of Approximately RMB 192 Million in Q1 2026 Tongling Jieya Biotechnology Co., Ltd. achieved operating revenue of approximately RMB 192 million in the first quarter of 2026, representing a year-on-year increase of 55.45%. Net profit attributable to shareholders of the listed company was approximately RMB 10.2685 million, up 2.04% year-on-year.

Jiachuang Technology Achieved Operating Revenue of Approximately RMB 134 Million in 2025 Xiamen Jiachuang Technology Co., Ltd. achieved operating revenue of approximately RMB 134 million in 2025, representing a year-on-year increase of 16.54%. Net profit attributable to shareholders of the listed company was approximately RMB 11.7154 million, up 211.21% year-on-year.

Shandong Xinhe Achieved Operating Revenue of Approximately RMB 109 Million in 2025 Shandong Xinhe Paper Engineering Co., Ltd. achieved operating revenue of approximately RMB 109 million in 2025, representing a year-on-year decrease of 14.18%. The tissue paper machine business saw a year-on-year revenue decline of 27.85% during the period, while the components products business achieved a high growth of 151.25%, becoming a bright spot in revenue growth.

Yiyi Achieved Operating Revenue of Approximately RMB 403 Million in Q1 2026 Tianjin Yiyi Hygiene Products Co., Ltd. achieved operating revenue of approximately RMB 403 million in the first quarter of 2026, representing a year-on-year decrease of 16.98%. Net profit attributable to shareholders of the listed company was approximately RMB 27.6852 million, down 48.82% year-on-year.

Winner Medical Publishes 2025 Annual Report and 2026 Q1 Report Winner Medical Co., Ltd. achieved operating revenue of approximately RMB 10.949 billion in 2025, representing a year-on-year increase of 21.69%. Net profit attributable to shareholders of the listed company was approximately RMB 768 million, up 10.44% year-on-year. In the first quarter of 2026, operating revenue was approximately RMB 2.679 billion, up 2.84% year-on-year. Net profit attributable to shareholders of the listed company was approximately RMB 251 million, up 1.18% year-on-year.

Coco Publishes 2025 Annual Report and 2026 Q1 Report Hangzhou Coco Healthcare Products Co., Ltd. achieved operating revenue of approximately RMB 1.150 billion in 2025, representing a year-on-year increase of 6.65%. Net profit attributable to shareholders of the listed company was approximately RMB 36.1187 million, up 15.87% year-on-year. In the first quarter of 2026, operating revenue was approximately RMB 291 million, up 3.97% year-on-year. Net profit attributable to shareholders of the listed company was approximately RMB 1.8798 million, down 89.89% year-on-year.